Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

49.14 +0.30 (+0.61%)

Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	365,664
Open	48.90
Bid (Size)	49.10 (700)
Ask (Size)	49.13 (100)
Prev. Close	48.84
Today's Range	48.51 - 49.74
52wk Range	41.50 - 90.32
Shares Outstanding	8,168,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗

December 03, 2025

Soleno just turned profitable for the first time—right as a major fund made its move.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

December 03, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Performance

YTD	+7.5%	+7.5%
1 Month	+7.0%	+7.0%
3 Month	-13.6%	-13.6%
6 Month	-41.6%	-41.6%
1 Year	+9.3%	+9.3%

More News

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

November 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future ↗

November 11, 2025

Via Benzinga

PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗

November 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm

November 11, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm

November 10, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

These stocks are moving in today's session ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

November 05, 2025

Via Chartmill

Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 04, 2025

Via Benzinga

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO

October 30, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 27, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 20, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 15, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 12, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

October 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?

Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?

Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?

The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market

What is the current price of Soleno Therapeutics, Inc. - Common Stock?

The current price of Soleno Therapeutics, Inc. - Common Stock is 49.14

When was Soleno Therapeutics, Inc. - Common Stock last traded?

The last trade of Soleno Therapeutics, Inc. - Common Stock was at 12/24/25 01:00 PM ET

What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?

The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 401.41M

How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?

Soleno Therapeutics, Inc. - Common Stock has 401M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.